Other languages Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
0.91 ^USD	+2.13%		+1.11%	-76.79%

May. 08	Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M	MT
May. 08	Transcript : Accelerate Diagnostics, Inc., Q1 2024 Earnings Call, May 08, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
Top Midday Decliners	Jan. 19
Sector Update: Health Care Stocks Weaker Late Afternoon	Jan. 16
Sector Update: Health Care	Jan. 16
Top Midday Decliners	Jan. 16
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper	Nov. 27
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Accelerate Diagnostics to Conduct 1-for-10 Reverse Stock Split; Shares Fall	23-07-10
Accelerate Diagnostics, Inc. is Heading Towards Bankruptcy	23-06-08
Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Accelerate Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29
Accelerate Diagnostics' Finance Chief Steve Reichling to Step Down; Successor Named	23-03-15
Accelerate Diagnostics, Inc. Announces Board Changes	23-03-08
Accelerate Diagnostics, Inc. Announces Board Changes	23-02-24
Accelerate Diagnostics Files Application With US FDA to Update PhenoTest BC Kit	22-12-19
Accelerate Diagnostics Submits 510(K) Application to FDA for Gram-Negative Menu Expansion and Breakpoint Updates for the Accelerate Phenotest(R) BC Kit	22-12-19
Accelerate Diagnostics, Inc. Announces Resignation of Ron Price as Chief Commercial Officer	22-12-13
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Other languages

Filters